Latest news with #SGH
Borneo Post
19 hours ago
- Health
- Borneo Post
‘From Sibu to Singapore'
Sarawak-born doctor proud to have become pioneer in colorectal surgery in Lion City, hails late wife as 'greatest supporter' Dr Goh regards the relocation to Singapore in 1981 as 'the defining step of his career'. THE move from Sarawak to Singapore in 1981 was indeed the defining step for Mukah-born Prof Dr Goh Hak Su. It later earned him the recognition of being one of the most respected figures in the field of colorectal surgery. 'Well, I grew up in a poor household in Mukah. 'I went to school and studied up to O-Level at Three Rivers School. 'That's the highest you could go in Mukah. Usually, after Form 5, the next step would be to go to Miri to do the A-Level,' he shared with thesundaypost during an exclusive interview recently. Dr Goh, now 77, could never forget how fortunate he was to be awarded an English scholarship after his O-Level, which enabled him to pursue A-Levels at the prestigious Sevenoaks School in the UK. He then went on to pursue two degrees – one in Biochemistry, and the other in Medicine – at the King's College London and the University of London. He then underwent training as a surgeon and obtained a Fellowship of the Royal College of Surgeons (FRCS) in England, before coming back to Sarawak in early 1980. 'There were very few doctors in Sarawak in those days. I thought that before coming back, I would be more useful if I were a surgeon rather than just a GP (general physician). 'As a GP, you treat general medical conditions, which is also important. 'But if someone came in bleeding or with appendicitis, I wouldn't be able to deal with it as a GP. 'So I trained as a surgeon after completing my medical degree. 'The whole point of training and going back was to serve Sarawak,' he said. 'Return to homeland' Upon his return in early 1980, Dr Goh was posted at Sarawak General Hospital (SGH) in Kuching. His wife Associate Professor Dr Cynthia Goh, also a trained doctor, had taken some time off to raise their son and daughter. Photo shows the old Lau King Howe Hospital in Sibu, where Dr Goh had served as its only surgeon from 1980 to 1981. — Photo from Dr Goh said after several months at the SGH, he was persuaded by the former deputy chief minister, the late Datuk Patinggi Tan Sri Dr Wong Soon Kai, to relocate to Lau King Howe Hospital (LKHH) in Sibu, where there were no surgeon at the time. 'It was a request that I graciously accepted,' said Dr Goh. He said including himself, there were two surgeons in Kuching at the time. 'The other was a more senior colleague. In Sibu, however, there was no surgeon stationed there. 'Datuk Patinggi Dr Wong, a great and highly-respected surgeon, approached me and said: 'We have two surgeons here in Kuching, but none in Sibu – why not serve where you're needed most'. 'So, after four months in Kuching, I agreed to move to Sibu.' 'One surgeon, many roles' Dr Goh then served at the LKHH as the sole surgeon, providing surgical care and covering not just Sibu, but the entire division at that time. 'I enjoyed my work at the LKHH very much. People came from Kanowit, Kapit, even as far as Belaga. 'Sometimes, though, we had patients with appendicitis who had to travel for two to three days just to reach us for surgery. 'Sadly, some did not make it.' As the only general surgeon in Sibu, Dr Goh performed a wide range of operations, from on the abdomen and lungs to, at times, heart and kidneys. 'I didn't do eye surgeries, because there was an eye surgeon; and there's one for O&G (obstetrics and gynaecology). 'The rest, I had to do myself. Obviously, it was very challenging. 'Given the limitations at the time, my team and I had to make do with what was available. 'It was a demanding environment, but it's also one that gave us invaluable experience and taught us to adapt effectively.' 'Decision shaped by circumstances' However, nearing the end of 1981 after having served in Sarawak for 18 months, Dr Goh left Sibu for Singapore. It was not a decision that he made lightly. 'It was driven by necessity,' he said, pointing out that the circumstances surrounding foreign spouses at the time made it almost impossible for his family to settle in Sarawak. In explaining this, he said Dr Cynthia was born in Hong Kong, but after having studied in the UK for so long, she was granted British citizenship. 'My wife, having studied in the UK for years, and my children, who were born in England, all held British passports. 'At that time, the situation was very different – they couldn't become Sarawak residents. 'My wife had to renew her permit every three months, and although she was a trained doctor, she wasn't allowed to work in Sarawak. 'It was very difficult,' he shared. 'A new chapter' After his family left Sarawak, Dr Goh joined the Department of Surgery at the National University of Singapore (NUS). It was in his first eight years with the university that he developed a special interest in colorectal surgery. 'Even at that time, we already knew that colorectal cancer was going to be a very important focus, because from the cancer registry, we could see that the numbers and the incidence were increasing very dramatically compared with the other types of cancers.' In 1989, Dr Goh was asked by Singapore's Ministry of Health to establish the Department of Colorectal Surgery at Singapore General Hospital. 'That's where it began. I started the first colorectal surgery programme in Singapore, as well as in Southeast Asia. In 1989, I established the Department of Colorectal Surgery at Singapore General Hospital, marking the beginning of the specialty in the region.' The department trained most colorectal surgeons in Singapore and provided fellowships and training to surgeons from across Southeast Asia, China, India, Bangladesh, and even as far as Australia and UK. In 2021, Singapore Health Services (SingHealth) and Duke-NUS Medical School established the Goh Hak Su Professorship in Colorectal Surgery, with a perpetual endowment, in honouring Dr Goh for pioneering the surgical specialty in Singapore, and also in Southeast Asia. A view of the wall showing the awards and recognitions conferred on Dr Goh, at a corner of the Goh Hak-Su Colon and Rectal Centre in Singapore. — Photo from However, it was only one part of the Goh's legacy. Dr Cynthia also left an equally profound impact in the field of palliative care. 'A wife's grace, a nation's care' Born on Nov 21, 1949, in Hong Kong into a family of doctors, Dr Cynthia pursued medicine in the UK. There, she met her future husband at St Bartholomew's Hospital in 1969, and married him in 1974. To Dr Goh, Dr Cynthia was 'simply remarkable – a woman of brilliance, with sheer drive and deep compassion'. 'She trained to become a physician, and completed a PhD in molecular biology, all while raising a family. 'She could do it all – housewife, doctor, scientist. 'She was a brilliant person,' he said. Dr Cynthia took a holistic approach to medicine, added Dr Goh. 'She believed that a person was never just a diagnosis. She treated people, not just illnesses.' That belief, said Dr Goh, shaped her life's work in palliative care, which was a nascent field in Asia back then. Archive photo shows Dr Cynthia (left) attending to a patient at St Joseph's Home during her earlier years in the field of palliative care. — Photo from Dr Cynthia began volunteering at St Joseph's Home and Hospice, Singapore in 1986, and went on to establish palliative care services at Singapore General Hospital and the National Cancer Centre Singapore (NCCS) in 1999. She also co-founded HCA Hospice Care in 1991, and served as its first president. 'Hospice Care Association (HCA) was a voluntary organisation. 'Doctors and nurses visited people in their homes so they didn't have to die in hospital,' said Dr Goh. Dr Goh says in recognition of her contributions, Dr Cynthia was hailed as the 'Mother of Palliative Care in Singapore'. Dr Cynthia's contributions helped bring palliative care into mainstream healthcare, and in 2008, she was appointed co-chair of the Worldwide Hospice Palliative Care Alliance (WHPCA). Even after being diagnosed with pancreatic cancer in 2020, Dr Cynthia remained focused on strengthening the field. She envisioned a lasting platform to support palliative care across Asia, and had laid the groundwork for what would become the Cynthia Goh Palliative Care Institute (CGPCI). 'Upon knowing that she was dying, she wanted the work to continue and grow. 'That's the legacy that she left behind,' said Dr Goh. Dr Cynthia passed away in February 2022, at the age of 72. In her honour, the CGPCI was launched on July 1, 2023, during the Eighth Singapore Palliative Care Conference, housed within the NCCS under Duke-NUS Medical School, where she had long championed the cause. Photo shows the Duke-NUS Medical School in Singapore, where together with SingHealth had established the Goh Hak Su Professorship in Colorectal Surgery in 2021, in honouring Dr Goh for pioneering the surgical specialty in Singapore, and also in Southeast Asia. — Photo from Funded initially by S$6 million (then, one Singapore dollar = RM3.19) in donations from family and friends, the institute's key objectives are to build regional palliative care capacity, train future leaders through the Cynthia Goh Fellowship, and serve as the permanent home of the Asia Pacific Hospice Palliative Care Network (APHN). In recognition of her contributions, Dr Cynthia was hailed as the 'Mother of Palliative Care in Singapore'. 'Measure success by purpose, not wealth' When asked what would be his advice for those from the younger generation aspiring to succeed, Dr Goh emphasised the importance of placing values above material gain. 'Never put money at the forefront of what you are doing. 'When we plan our life, we should not plan with the idea of wanting to be rich first. 'When you have money in front of you, and that's your goal, then to me, life would not be so fulfilling.' He added that one must always strive to do their best, making the most of whatever opportunities being given to them. He said: 'I was very lucky. I wanted to become a doctor, and I was given the opportunity to become one. 'So, I always wanted to be as good as I could, and that has enriched my life tremendously.' Dr Goh also expressed his gratitude for the unwavering support from Dr Cynthia, who shared his values and stood by him throughout their time together. 'I was trained in England and had no obligation to return to Sarawak – I wasn't bonded. 'But I wanted to come back to serve. 'Most people, at that time, had wondered why we chose to move to a place like Sibu, as it's not a big city. 'But Cynthia supported me fully. She believed that it was important for me. 'It was unfortunate that we could not stay longer in Sarawak, but we were given great opportunities in Singapore to develop, and that's where we went.'
Hindustan Times
26-05-2025
- Health
- Hindustan Times
192 negligence cases recorded in five years
The Pune district has reported 192 medical negligence cases over the past five years, according to data from the district expert panel that investigates such complaints. The expert committee of Sassoon General Hospital(SGH) and BJ Medical College (BJMC), is responsible for probing alleged medical negligence by healthcare professionals in the district. Between 2020 and April 2025, the panel identified negligence in 192 cases, officials confirmed. So far in 2025, seven cases have been reported. Of these, negligence was confirmed in just three cases to date, officials said. According to the officials, the highest number of cases were reported in 2023 with 54 instances in the Pune district alone. A year later, 50 cases were reported — 46 from Pune district and the remaining four from Satara (2), Ahmednagar (1), and Sangli (1) district, said the officials. Additionally, currently, there are 112 pending cases, highlighting significant delays in the inquiry process and the need for expediting the investigations. Dr Yallapa Jadhav, medical superintendent, SGH, said the committees are formed and probes are conducted in the alleged complaints of medical negligence as per the state government to Government Resolution (GR) issued in 2010. 'The district-level committee is constituted to look into allegations of medical negligence against doctors prior to the registration of an FIR. The action by Cops or other authorities is taken based on the report given by the committee,' he said. As per official data, since 2020, a total of 87 committees have been constituted to investigate these incidents.
CNA
23-05-2025
- Health
- CNA
Systemic sclerosis causes 1 in 2 deaths within 4 years of diagnosis
A S$6 million grant at the Singapore General Hospital will fund a new project for systemic sclerosis patients. The aim is to better diagnosis and personalised treatment for the disease that has poor survival rates, killing one in two Asian patients within four years of diagnosis. Researchers will analyse patients' genes, immune systems, gut bacteria and more over the next five years. Associate Professor Andrea Low, Lead of the Singapore Systemic Sclerosis Precision Medicine Project and Senior Consultant at SGH, explains why Asian patients have poor survival rates with this disease and the factors contributing to it. She also points out how the Singapore Systemic Sclerosis Precision Medicine Project differs from existing programmes treating this disease.
Yahoo
23-05-2025
- Health
- Yahoo
SGH to lead $5.8m research project to combat deadly autoimmune disease
SINGAPORE – A team of researchers led by the Singapore General Hospital (SGH) is embarking on a five-year-long $5.77 million research project to better diagnose and treat systemic sclerosis – a life-threatening autoimmune disease which has largely unknown underlying causes. To do so, researchers aim to develop a predictive algorithm that can better detect those at risk of worse outcomes, and validate an imaging technique that can sift out earlier those whose condition is set to deteriorate. Systemic sclerosis, or scleroderma, afflicts about eight out of 100,000 people in Asian populations. In Singapore, it is estimated that around 500 to 600 patients are living with the condition at any one point in time. Some 10 to 15 patients are newly diagnosed every year. The exact cause of the disease is not fully understood, but it is believed to be a combination of genetic and environmental factors. For example, a viral infection can trigger individuals with a genetic disposition to develop the rare disease. The condition causes the body's immune system to mistakenly target and attack its healthy tissues and cells. This can result in thickening and hardening of the skin, lungs and other internal organs. The research project, funded by an A*Star grant, was announced at SGH in a media briefing on May 22. Known as the Singapore Systemic Sclerosis Precision Medicine Project, or Sysmic, it brings together clinician scientists, laboratory and big-data scientists and imaging specialists to analyse data derived from patients' genes and immune system. The goal is to gain better insights into how the disease progresses in different patients. About 300 patients will be recruited for the study. Participating institutes include the SingHealth Duke-NUS Translational Immunology Institute, National Neuroscience Institute, Lee Kong Chian School of Medicine at Nanyang Technological University, Tan Tock Seng Hospital, National University Hospital and Sengkang General Hospital. Sysmic lead Andrea Low said: 'Scleroderma is particularly challenging as it affects each patient differently in both severity and progression. With Asian patients showing poorer survival rates and known genetic differences in scleroderma risk, the goal is to develop more personalised treatments and better ways to predict how the disease will progress.' Research has shown that just 52 per cent of Asians are still alive nine years after their diagnosis, compared with 76 per cent of Caucasians. In Singapore, patients with mild or localised symptoms often have a normal life expectancy. However, among those whose lungs, heart and kidneys are affected, half die of the disease within two to three years of its onset. Associate Professor Low, who is also a senior consultant at SGH's department of rheumatology and immunology, said the disease is very complex because it can cause three interconnected processes: inflammation, vascular damage and excessive fibrosis. Often, it is not clear which process is taking place in a patient. This makes it hard to administer the right treatment to slow down the progression of the disease. To better target the right underlying process, researchers on the project will study in detail how scleroderma patients' immune systems behave. With the data, they hope to develop a preliminary predictive algorithm that can give better insights into a patient's prognosis. 'It could tell us which one of the three processes is happening, so we can use the appropriate drugs to treat these patients,' said Prof Low. Lung fibrosis, where scarring in the organ makes it hard for patients to breathe, is one of the major causes of death in scleroderma. Asians who develop the disease tend to have worse lung fibrosis, said Prof Low. The research project will aim to validate a new imaging technique that can better detect if lung cells are actively producing fibrous tissue. Explaining the technique, Prof Low said radiotracers are injected into a patient and will light up on a scan when cells are actively producing tissue. 'The problem now is that we cannot quite use (this technique) because we don't know what's the threshold (before we take action). Do we say 'even if I see one tiny spot, we should treat', or maybe we treat when it's 10 per cent lit up,' she said, adding that the research will help to determine the threshold. She also hopes the research project will be able to help current patients like Ms Haslina Wanoor, 45. Ms Haslina was diagnosed with the disease in 2008, when she was 28. Three years later, her condition deteriorated when her lung fibrosis worsened, leaving her breathless. In 2013, she underwent a stem cell transplant that bought her about five years of stability. Today, she is on palliative care and needs supplemental oxygen supply from an oxygen concentrator 24 hours a day. Prof Low said that while Ms Haslina's lung fibrosis is in the advanced stages, doctors are trying to stabilise the disease with medication. With a more precise lung imaging method, doctors will be better able to more confidently detect what is happening and escalate treatment if needed. For patients, this can help reduce suffering and prolong lifespan when timely treatment is given. For Ms Haslina, her priority now is her 20-year-old daughter. 'I hope I'll still be able to fulfil my duties as a mother, and see her go through more milestones of her life, like graduation or even marriage.' Source: The Straits Times © SPH Media Limited. Permission required for reproduction Discover how to enjoy other premium articles here
Straits Times
23-05-2025
- Health
- Straits Times
SGH to lead $5.8m research project to combat deadly autoimmune disease
Systemic sclerosis, or scleroderma, afflicts around eight per 100,000 people in Asian populations. ST PHOTO: LIM YAOHUI SINGAPORE - A team of researchers led by the Singapore General Hospital (SGH) is embarking on a five-year-long $5.77 million research project to better diagnose and treat systemic sclerosis – a life-threatening autoimmune disease which has largely unknown underlying causes. To do so, researchers aim to develop a predictive algorithm that can better detect those at risk of worse outcomes, and validate an imaging technique that can sift out earlier those whose condition are set to deteriorate. Systemic sclerosis, or scleroderma, afflicts around eight per 100,000 people in Asian populations. In Singapore, it is estimated that around 500 to 600 patients are living with the condition at any one point in time. Some 10 to 15 patients are newly diagnosed every year. The exact cause of the disease is not fully understood, but it is believed to be a combination of genetic and environmental factors. For example, a viral infection can trigger individuals with a genetic disposition to develop the rare disease. The condition causes the body's immune system to mistakenly target and attack its healthy tissues and cells. This can result in thickening and hardening of the skin, lungs and other internal organs. The research project, funded by an A* Star grant, was announced at SGH in a media briefing on May 22. Known as the Singapore Systemic Sclerosis Precision Medicine Project or Sysmic, the project brings together clinician scientists, laboratory and big data scientists, and imaging specialists to analyse data derived from patients' genes and immune system. The goal is to gain better insights into the disease progresses in different patients. About 300 patients will be recruited for the study. Participating institutes include the SingHealth Duke-NUS Translational Immunology Institute, National Neuroscience Institute, Lee Kong Chian School of Medicine at Nanyang Technological University, Tan Tock Seng Hospital, National University Hospital, and Sengkang General Hospital. Sysmic lead Associate Professor Andrea Low said: 'Scleroderma is particularly challenging as it affects each patient differently in both severity and progression. With Asian patients showing poorer survival rates and known genetic differences in scleroderma risk, the goal is to develop more personalised treatments and better ways to predict how the disease will progress.' Research has shown that just 52 per cent of Asians are still alive nine years after their diagnosis, compared to 76 cent of Caucasians. In Singapore, patients with mild or localised symptoms often maintain a normal life expectancy. However, among those whose lung, heart and kidneys are affected, half succumb to the disease within two to three years of its onset. Prof Low, who is also a senior consultant at SGH's department of rheumatology and immunology, said the disease is very complex because it can cause three interconnected processes: inflammation, vascular damage and excessive fibrosis. Oftentimes , it is not clear which process is taking place in a patient, which then makes it hard to administer the right treatment to slow down the progression of the disease. To better target the right underlying process, researchers on the project will study in detail how scleroderma patients' immune systems behave. With the data, they hope to develop a preliminary predictive algorithm that can give better insights into a patient's prognosis. 'It could tell us which one of the three processes is happening, so we can use the appropriate drugs to treat these patients,' said Prof Low. Lung fibrosis, where the scarring in the organ makes it hard for patients to breathe, is one of the major causes of death in scleroderma. Asians that develop the disease tend to have worse lung fibrosis, said Prof Low. The research project will aim to validate a new imaging technique that can better detect if lung cells are actively producing fibrous tissue. Explaining the technique, Prof Low said that radiotracers are injected into a patient, and will light up on a scan when cells are actively producing tissue. 'The problem now is that we cannot quite use (this technique) because we don't know what's the threshold (before we take action). Do we say even if I see one tiny spot, we should treat, or maybe we treat when it's 10 per cent lit up,' said Prof Low, adding that the research will help to deterimine the threshold. Prof Low also hopes the research project will be able to help current patients like Ms Haslina Wanoor, 45. She was diagnosed with the condition in 2008 when she was 28. Three years later, her condition worsened when her lung fibrosis deteriorated, leaving her breathless. In 2013, she underwent a stem cell transplant which bought her about five years of stability. Today, she is on palliative care and needs supplemental oxygen supply from an oxygen concentrator 24 hours a day. Prof Low said that while Ms Haslina's lung fibrosis is in the advanced stages, doctors are trying to stabilise the disease with medication. With a more precise lung imaging method, doctors will be better able to more confidently detect what is happening and escalate treatment if needed. For patients in general, this will help cut suffering and prolong lifespan when timely treatment is given. For Ms Haslina, her priority now is her 20-year-old daughter. 'I hope I'll still be able to fulfil my duties as a mother, and see her go through more milestones of her life, like graduation or even marriage.' Join ST's WhatsApp Channel and get the latest news and must-reads.
